News|Articles|August 28, 2023
Best Practices for Analysis of In Vitro Transcribed (IVT) mRNA Using the Agilent Fragment Analyzer systems
Author(s)Agilent
This technical overview discusses best handling practices for IVT mRNA and analysis with the Fragment Analyzer systems, including sample handling and quantification tips.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
2
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
3
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
4
Biopharma’s 2025 Transformation: A Recap of Our Top 10 Articles
5